• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Identifying Novel Therapeutic Targets in Leukaemia Stem Cells

Grant number: 1202192 | Funding period: 2020 - 2024

Completed

Related publications (1)

Scholarly works icon

Catalytic Inhibition of KAT6/KAT7 Enhances the Efficacy and Overcomes Primary and Acquired Resistance to Menin Inhibitors in MLL Leukemia

SJV Gordon, F Perner, L Macpherson, KA Fennell, DV Wenge, W Bourgeois, T Klaus, T Plenge, A Murat, J Petrovic, J Horvath, JQ Cao, JD Lapek, S Uryu, JR White, EYN Lam, XJ Mu, YC Chan, A Gillespie, BJ Blyth

2025-10-01

Targeting MYST acetyltransferases is an exciting therapeutic opportunity in acute myeloid leukemia (AML). In this study, we define..

University of Melbourne Researchers

Prof Mark Dawson's Profile Picture
Prof Mark Dawson

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224